Abiopharma

🔍 Shure Jared (Executive)

Company: Childrens Place, Inc. (PLCE)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 4,181 shares of Common Stock, par value $0.10 per share at $3.32 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 151,618.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 2,019 shares of Common Stock, par value $0.10 per share at $3.32 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 149,599.00 | transaction_form_type: 4 | Footnotes: F3, F7
• Acquired 7,525 shares of Common Stock, par value $0.10 per share (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 157,124.00 | transaction_form_type: 4 | Footnotes: F4, F7
• Sold 2,360 shares of Common Stock, par value $0.10 per share at $3.32 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 154,764.00 | transaction_form_type: 4 | Footnotes: F5, F7
• Sold 285 shares of Common Stock, par value $0.10 per share at $3.32 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 154,479.00 | transaction_form_type: 4 | Footnotes: F6, F7

Footnotes:

• F1: The shares reported were withheld to pay tax liabilities incident to the vesting of performance-based restricted stock units ("2024 PRSUs") on April 15, 2026, as fully described in the Reporting Person's Statement of Changes in Beneficial Ownership on Form 4 filed on November 5, 2024.
• F2: As disclosed in the Definitive Proxy Statement on Schedule 14A filed by The Children's Place, Inc. (the "Company") on April 10, 2026, the 2024 PRSUs tie payouts directly to Company performance based on pre-established performance metrics for fiscal 2025 for vesting year 2 of such awards, using an Adjusted Free Cash Flow metric for fiscal 2025. The Company's performance fell below the threshold amount of Adjusted Free Cash Flow for fiscal 2025 which resulted in 0% vesting for such awards. However, on March 11, 2026, the Company's Human Capital & Compensation Committee determined to award Mr. Shure with one hundred percent (100%) of the shares referred to above regarding the second vesting year of the 2024 PRSUs.
• F3: These shares reported were withheld to pay tax liabilities incident to the vesting of dilution protection performance-based restricted stock units described in footnote 1 above, on April 15, 2026.
• F4: The shares reported represent shares of Common Stock, par value $0.10 per share, of The Children's Place, Inc. (the "Company"), underlying performance shares granted under the Company's 2011 Equity Incentive Plan (the "Plan") on June 9, 2023. As a result of the occurrence of the Change in Control at the Company on February 13, 2024, and in accordance with the terms and conditions of the Plan, all performance shares granted but unvested had performance criteria eliminated and the shares reported vested and were delivered on April 15, 2026.
• F5: These shares reported were withheld to pay tax liabilities incident to the vesting of the restricted stock units described in footnote 4 above, on April 15, 2026.
• F6: These shares reported were withheld to pay tax liabilities incident to the vesting of dilution protection restricted stock units described in footnote 4 above, on April 15, 2026.
• F7: Includes dividend equivalent shares that have accrued thereon.